CANLI
Yükleniyor Veriler getiriliyor…
SCI-Expanded JCR Q3 Özgün Makale Scopus
Does Sericin, as a Novel Pleurodesis Agent, Have Higher Effectiveness Compared to Talcum Powder, Doxycycline, and Silver Nitrate Pleurodesis?
Archivos de Bronconeumologia 2019 Cilt 55 Sayı 7
Scopus Eşleşmesi Bulundu
7
Atıf
55
Cilt
357-367
Sayfa
Özet
Introduction: The usefulness of sericin as pleurodesis agent has previously been described. Present study aims to compare sericin pleurodesis regarding success, effectiveness, tolerability, and side-effects. Methods: Adult, 12-week-old Wistar-albino rats (n = 60), divided to five groups as sericin, talcum-powder, doxycycline, silver-nitrate and control. Agents were administrated through left thoracotomy, rats sacrificed twelve-days after. Results: Highest ratio of collagen fibers was observed in sericin group, and the intensity was higher than talcum-powder group (p < 0.05). Compared to silver nitrate, sericin group displayed better mesothelial reaction, and multi-layer mesothelium was also better (p < 0.05). Foreign body reaction and emphysema were less frequent in sericin group (p < 0.05). The presence of biological tissue in parenchyma was less prominent in sericin group (p < 0.05). Foreign body reaction on thoracic wall was less common in sericin group (p < 0.05). Presence of biological tissue glue in thoracic wall was less prominent in sericin group (p < 0.05). Glomerular degeneration was lower in sericin group compared to the silver nitrate group (p < 0.05), and tubular degeneration was less common in sericin group than talcum group (p < 0.05). Pericarditis was less common in sericin group compared to the other groups (p < 0.05). Conclusion: As an intrinsic, natural glue protein, sericin protects the lung parenchyma and tissues, and its glue-like characteristics enable pleurodesis. The success of sericin in pleurodesis was demonstrated in the present study based on investigations of the pleurae. Being cost-effective and better tolerated agent associated with a low potential of side effects, sericin is more effective, less expensive and provides more lung parenchyma protection.

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 7.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi Otomatik ISSN Eşleştirmesi 2019 yılı verileri
Archivos de Bronconeumologia
Q3
SJR Quartile
0,287
SJR Skoru
61
H-Index
🔓
Açık Erişim
Kategoriler: Pulmonary and Respiratory Medicine (Q3)
Alanlar: Medicine
Ülke: Spain · Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR)
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir. Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.

Anahtar Kelimeler

Bu makale için anahtar kelime bilgisi bulunmuyor.

Makale Bilgileri

Dergi Archivos de Bronconeumologia
ISSN 0300-2896
Yıl 2019 / 7. ay
Cilt / Sayı 55 / 7
Sayfalar 357 – 367
Makale Türü Özgün Makale
Hakemlik Hakemli
Endeks SCI-Expanded
JCR Quartile Q3
Teşvik Puanı 0,75 · YÖKSİS Akademik Teşvik
Yayın Dili İngilizce
Kapsam Uluslararası
Toplam Yazar 6 kişi
Erişim Türü Basılı
Alan Sağlık Bilimleri Temel Alanı Göğüs Cerrahisi

YÖKSİS Yazar Kaydı

Yazar Adı YAZICIOĞLU ALKIN, UYSAL SERKAN, ŞAHİNOĞLU TUBA, SUBAŞI MAHMUT, DEMİRAĞ FUNDA, YEKELER ERDAL
YÖKSİS ID 6684298

Metrikler

Scopus Atıf 7
Havuz Atıfları 0
JCR Quartile Q3
Teşvik Puanı 0,75
Yazar Sayısı 6